Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis

Stopped The study was prematurely terminated due to slow enrollment beyond the planned study timelines.

Conditions

• Sinusitis
• Bacterial Infections

Interventions

• DRUG: Moxifloxacin (Avelox, BAY12-8039)
• DRUG: Amoxicillin/Clavulanate

Sponsor

Bayer